A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics (Q41043010)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 June 2017
edit
Language Label Description Also known as
English
A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics
scientific article published on 22 June 2017

    Statements

    A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics (English)
    1 reference
    Jeffrey E Ming
    1 reference
    Ruth E Abrams
    1 reference
    Derek W Bartlett
    1 reference
    Mengdi Tao
    1 reference
    Tu Nguyen
    1 reference
    Howard Surks
    1 reference
    Katherine Kudrycki
    1 reference
    Ananth Kadambi
    1 reference
    Christina M Friedrich
    1 reference
    Nassim Djebli
    1 reference
    Britta Goebel
    1 reference
    Alex Koszycki
    1 reference
    Meera Varshnaya
    1 reference
    Joseph Elassal
    1 reference
    Poulabi Banerjee
    1 reference
    William J Sasiela
    1 reference
    Michael J Reed
    1 reference
    Jeffrey S Barrett
    1 reference
    Karim Azer
    1 reference
    22 June 2017
    1 reference
    11
    1 reference
    1177625017710941
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit